Servier

This study is testing whether a daily pill called vorasidenib can slow down or stop the growth of recurrent low-grade brain tumors (gliomas) in Asian patients who have a specific genetic mutation. Participants will take either the drug or a placebo pill, and researchers will trac…

This study is testing a daily oral medication called ivosidenib for Japanese patients with advanced bile duct cancer that has a specific genetic change (IDH1 mutation) and has worsened after one or two prior treatments. The main goal is to see if the treatment can keep the cancer…